papaverine has been researched along with alprostadil in 230 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 33 (14.35) | 18.7374 |
| 1990's | 141 (61.30) | 18.2507 |
| 2000's | 43 (18.70) | 29.6817 |
| 2010's | 12 (5.22) | 24.3611 |
| 2020's | 1 (0.43) | 2.80 |
| Authors | Studies |
|---|---|
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Kramer, L; McGuffey, E | 1 |
| Chiang, CP; Huang, CH; Wang, CJ; Wu, CC | 1 |
| Chiang, HS; Chiang, WH; Wen, TC; Wu, CC | 1 |
| Puolakka, VM | 1 |
| Allen, RP; Brendler, CB; Engel, RM; Smolev, JK | 1 |
| Belgrano, E; Deriu, M; Pirozzi-Farina, F; Salisci, E; Siracusano, S; Trombetta, C | 1 |
| Becker, HC; Brähler, E; Rudnick, J; Schroeder-Printzen, J; Weidner, W; Weiske, WH | 1 |
| Bellorofonte, C; Dell'Acqua, S; Ruoppolo, M; Tombolini, P; Zaatar, C | 1 |
| Alken, P; Jünemann, KP; Köhrmann, KU; Löbelenz, M; Rassweiler, J; Seemann, O; Tschada, R | 1 |
| Alachkar, F; Alsweis, S; Courthéoux, P; Evrard, C; Henriet, JP; Maïza, C; Maïza, D; Rattez, C; Théron, J | 1 |
| Abdel-Aziz, AB; el Dakhli, MR; Fahmi, IM; Mahmoud, KZ | 1 |
| Alvarez, E; Andrés, A; Díaz González, R; Fernández Aparicio, T; Morales, JM; Pamplona, M; Rodriguez Antolin, A | 1 |
| Chan, JY; Chan, SH; Chang, LS; Chen, KK; Chen, MT | 1 |
| Gonzalez, J; Hollander, JB; Norman, T | 1 |
| Chen, JK; Hwang, TI; Yang, CR | 1 |
| Bemelmans, BL; Debruyne, FM; Doesburg, WH; Meuleman, EJ; Skotnicki, SH; van Asten, WN | 1 |
| Baert, AL; Peene, P; Steeno, O; Wilms, G | 1 |
| Alvarez González, E; Chandeck Montesa, K; Chen Jiménez, J; Rodríguez Antolín, A; Tamayo, JC | 1 |
| Cherry, DJ; Earle, CM; Keogh, EJ; Ker, JK; Lord, DJ; Tulloch, AG | 1 |
| Bondil, P; Bouchot, O; Navratil, H | 1 |
| Barada, JH; Bennett, AH; Carpenter, AJ | 1 |
| De Bruin, D; Dormehl, IC; Du Plessis, DJ; Jacobs, L; Maree, M | 1 |
| Otani, T | 1 |
| Levin, RD; Lidgi, S; Moskovitz, B; Vardi, Y | 1 |
| Chu, HW; Ho, WL; Hwang, TI; Yang, CR | 1 |
| Bellorofonte, C; Dell'Acqua, S; Ferri, PM; Ruoppolo, M; Tagliaferri, A; Tombolini, P; Yamak, R; Zaatar, C | 1 |
| Albrecht, K; Bar-Moshe, O; Dittrich, A; Vandendris, M | 1 |
| Hilson, AJ; Lewis, CA | 1 |
| Stricker, P | 1 |
| Jonas, U; Schaebsdau, FH; Stief, CG; Wetterauer, U | 1 |
| Richardson, JD | 1 |
| Adaikan, PG; Lau, LC; Ratnam, SS; Susheela, K; Vasatha, KS | 1 |
| Floth, A; Schramek, P | 1 |
| Chiang, CP; Chou, YH; Huang, CH; Liu, LC; Liu, LH; Tan, LB; Wu, CC | 1 |
| Ishii, N; Shirai, M | 1 |
| Collins, JP; Kattan, S; Mohr, D | 1 |
| Kaplan, HS | 1 |
| Weiske, WH | 2 |
| Kuhn, W; Schurch, B | 1 |
| Schrey, A | 1 |
| Earle, CM; Glatthaar, C; Keogh, EJ; Lord, DJ; Tulloch, AG; Watters, GR; Wisniewski, ZS | 1 |
| Dittrich, A; Vandendris, M | 1 |
| Ahmed, M; Akhtar, MA; Bomanji, J; Rana, MH; Sadiq, M; Siraj, QH | 1 |
| Asakawa, M; Kashiwara, N; Kawashima, H; Maekawa, T; Nishio, S; Tanaka, H; Yasumoto, R; Yoshimura, R | 1 |
| Akhtar, MA; Siraj, QH | 1 |
| Dveksler, G; Franchi, AM; Gimeno, AL; Gimeno, MA; Gonzalez, ET | 1 |
| Rudnick, J | 1 |
| Zorgniotti, AW | 1 |
| Chang, CH; Chang, CL; Hwang, TI; Lue, TF; Wu, HC; Yang, CR | 1 |
| Erickson, DR; Hardin, TC; Hudnall, CH; Novicki, DE; Sarosdy, MF | 1 |
| Porst, H | 3 |
| Samaha, AM; Seidmon, EJ | 1 |
| Aboseif, SR; Benard, F; Bosch, RJ; Breza, J; Lue, TF; Stackl, W; Stief, CG; Tanagho, EA | 1 |
| Adaikan, PG; Ratnam, SS | 1 |
| Reiss, H | 1 |
| Lee, LM; Stevenson, RW; Szasz, G | 1 |
| Esumi, N; Hashida, T; Imashuku, S; Nakajima, F; Todo, S; Tsunamoto, K | 1 |
| Eagle, JP; Robbins, SJ | 1 |
| Floth, A; Holzmann, RM; Schramek, P | 1 |
| Schramek, P; Waldhauser, M | 1 |
| Arizono, N; Ogita, S; Takahashi, T; Tokiwa, K | 1 |
| Loughnane, MH; Russo, M; Salganicoff, L; Sevy, RW | 1 |
| DeYoung, NJ; Duncan, HJ; Faris, IB | 1 |
| Hayakawa, K; Inoue, S; Munakata, H; Nara, K; Ono, K; Sato, S; Takahashi, K | 1 |
| Bhathal, PS; Grossman, HJ | 1 |
| Kakkar, VV; Zahavi, J; Zahavi, M | 2 |
| Clare, KA; Scrutton, MC; Thompson, NT | 1 |
| Sass, SP; Sheppard, H; Tsien, WH | 1 |
| Coquil, JF; Franks, DJ; Hamet, P; Tremblay, J | 1 |
| Azuma, H; Hidaka, H; Nishikawa, M; Yamakado, T | 1 |
| Fujiwara, K; Goto, Y; Imashuku, S; Ogita, S; Sugano, T; Todo, S | 1 |
| Anderson, DW; Crowle, AJ | 1 |
| Akimoto, A; Matsumoto, K; Obata, T; Shibata, K; Tsuboshima, M; Tsuda, T | 1 |
| Aragona, F; Calabrò, A; Italiano, G; Pagano, F | 1 |
| Hosking, DH; Muruve, N | 1 |
| Bancroft, J; Malone, N | 1 |
| Hayashi, S; Iwai, Y; Kawano, M; Kono, T; Matsuda, J; Minami, H; Omachi, T; Sakakura, T; Yamamoto, S; Yasumoto, R | 1 |
| Goldstein, I; Hatzichristou, DG; Namburi, S; Pescatori, ES | 1 |
| Goldwasser, B; Hanani, J; Shalhav, A; Shenfeld, O; Vardi, Y | 1 |
| Barbieri, L; Bergamaschi, F; Ferini-Strambi, L; Guazzoni, G; Montorsi, F; Rigatti, P | 1 |
| Barbieri, L; Bergamaschi, F; Da Pozzo, L; Guazzoni, G; Montorsi, F; Orlandini, A; Rigatti, P | 1 |
| Bergamaschi, F; Dodesini, A; Guazzoni, G; Miani, A; Montorsi, F; Pizzini, G; Rigatti, P | 1 |
| DePalma, RG; Druy, EM; Massarin, E; Miller, HC; Olding, M; Schwab, FJ; Yu, GW | 1 |
| Kubota, M; Nakabou, Y; Ojima, M; Takada, K | 1 |
| Kropman, RF; Lycklama à Nijeholt, AA; Meinhardt, W; Vermeij, P; Zwartendijk, J | 1 |
| Asase, D; Govier, FE; Hefty, TR; McClure, RD; Pritchett, TR; Weissman, RM | 1 |
| Chen, J; Godschalk, MF; Katz, PG; Mulligan, T | 1 |
| Kropman, RF; Lycklama, GA; Meinhardt, W; Nijehold, A; Schipper, J; van Oostayen, JA; Zwinderman, KH | 1 |
| Borges, FD | 1 |
| Tordjman, G | 1 |
| Krishnan, KR; Soni, BM; Vaidyanathan, S | 1 |
| Hsu, GL; Lue, TF; Martinez-Piñeiro, L; Tanagho, EA; Trigo-Rocha, F; von Heyden, B | 1 |
| Desvaux, P; Mimoun, S | 1 |
| Beckmann, R; Goessl, C; Knispel, HH | 1 |
| Becker, AJ; Djamilian, MH; Jonas, U; Kuczyk, M; Stief, CG; Thon, WF; Truss, MC | 1 |
| Butler, RN; Hoffman, E; Lewis, MI; Whitehead, ED | 1 |
| Kimblad, PO; Steen, S | 1 |
| Del Noce, G; Fontana, D; Rolle, L; Rosso, C; Tamagnone, A | 1 |
| Melman, A; Valdevenito, R | 1 |
| Chang, WC; Lin, JS; Lui, SM | 1 |
| Bergamaschi, F; Guazzoni, G; Miani, A; Montorsi, F; Pizzini, G; Pozza, G; Rigatti, P; Zucconi, M | 1 |
| Armstrong, DK; Convery, AG; Dinsmore, WW | 1 |
| Bancroft, J; Gutierrez, P; Pye, S | 1 |
| Chao, R; Clowers, DE | 1 |
| Hertfelder, HJ; Peskar, BA; Sticht, G; van Ahlen, H | 1 |
| Gibbons, RP; Govier, FE; Kramer-Levien, D; McClure, RD; Pritchett, TR; Weissman, RM | 1 |
| Montague, DK | 1 |
| Albano, GJ; Golimbu, M; Katlowitz, N; Morales, P; Patsias, G | 1 |
| Cocimano, V; Griffa, D; Marino, G; Pastorini, S; Pugno, E | 1 |
| Angermeier, KW; Jordan, GH | 1 |
| Derouet, H; Zehl, U | 1 |
| Moriel, EZ; Rajfer, J | 1 |
| Bellan, JA; Domer, FR; Hellstrom, WJ; Higuera, TR; Kadowitz, PJ; Minkes, RK; Sikka, SC; Wang, R | 1 |
| Armenakas, NA; Dixon, CM; Hricak, H; Lue, TF; McAninch, JW | 1 |
| Donatucci, CF; Kaula, N; Lue, TF; von Heyden, B | 1 |
| Albano, GJ; Golimbu, M; Katlowitz, NM; Morales, P | 1 |
| Cheng, JT; Jou, YC; Lin, JS; Lin, YM | 1 |
| Chiang, HS; Kao, YH; Sheu, MT | 1 |
| Bechara, A; Casabé, A; Chéliz, G; Fredotovich, N; Romano, S | 1 |
| Donatucci, CF; Henderson, D; Limoge, JP; Olins, E | 1 |
| Benejan Gual, J; Cuesta Presedo, JM; Gil Martínez, P; Gonzalvo Ibarra, A; Ríoja Sanz, LA; Rodríguez Vela, L | 1 |
| de la Fuente, RB; Lycklama à Nijeholt, AA; Meinhardt, W; Vermeij, P; Zwartendijk, J | 1 |
| Brekke, I; Christiansen, E; Purvis, K | 1 |
| Mills, RD; Sethia, KK | 2 |
| Bennett, CJ; Bennett, JK; Chancellor, MB; Finocchiaro, MV; Foote, JE; Green, BG; Hirsch, IH; Juma, S; Killorian, RW; Linsenmeyer, TA; Lloyd, K; Razi, S; Rivas, DA; Watanabe, T | 1 |
| Gianotten, WL; Slob, AK | 1 |
| Lin, JS; Lin, YM | 1 |
| Chun, SS; Fenemore, J; Heaton, JP; Johnston, B; Morales, A | 1 |
| McMahon, CG | 3 |
| Dluhy, RG; Jodbert, P; Kifor, I; Sullivan, MP; Vickers, MA; Williams, GH | 1 |
| Knoll, LD | 1 |
| Bechara, A; Casabé, A; Chéliz, G; Fredotovich, N; Rey, H; Romano, S | 2 |
| Sussman, H; Virag, R | 1 |
| Ishii, N; Miura, K; Nagao, K; Shirai, M; Takanami, M | 1 |
| Hansberry, KL; Soderdahl, DW; Thrasher, JB | 1 |
| Garcia-Reboll, L; Goldstein, I; Mulhall, JP | 1 |
| Glina, S; Pagani, E; Puech-Leão, P; Reis, JM | 1 |
| Daller, M; Goldstein, I; Gupta, S; Krane, RJ; Mulhall, JP; Park, K; Payton, TR; Salimpour, P; Traish, AM | 1 |
| Sogari, PR; Souto, CA; Telöken, C | 1 |
| Angle, JF; deHoll, JD; Shin, PA; Steers, WD | 1 |
| de Meyer, JM; Thibo, P | 1 |
| Granegger, S; O'Grady, J; Rodrigues, M; Sinzinger, H; Stackl, W | 2 |
| Angermeier, KW; Fazeli-Matin, S; Lakin, MM; Montague, DK | 1 |
| Gingell, JC | 1 |
| Giuliano, F; Jardin, A | 1 |
| Zaher, TF | 1 |
| Engel, JD; McVary, KT | 1 |
| Timmermans, L | 1 |
| Andrisano, V; Bertaccini, A; Carparelli, F; Cavrini, V; Gotti, R; Martorana, G; Soli, M | 1 |
| Kaplan, SA; Kohn, IJ; Reis, RB; Shabsigh, R; Te, AE | 1 |
| Adbel-Gawad, T; Asaad, T; Ghanem, H; Sherif, T | 1 |
| Abdallah, HM | 1 |
| Baniel, J; Israilov, S; Livne, P; Segenreich, E; Shmueli, J | 1 |
| Kamata, N; Kanamaru, K; Kuga, Y; Nakamura, F; Waga, S | 1 |
| Apostolidis, A; Hatzichristou, DG; Hatzimouratidis, K; Ioannidis, E; Kalinderis, A; Yannakoyorgos, K | 1 |
| Acar, O; Alici, B; Culha, M; Mutlu, N | 1 |
| Christiansen, E; Egdetveit, I; Purvis, K | 1 |
| Johnson, H; McMahon, CG; Samali, R | 1 |
| Enria, T; Favre, M | 1 |
| Abdullaev, IA; Kukharkin, SA; Nesterov, SN; Shcheplev, PA; Sidorov, DV | 1 |
| Bivalacqua, TJ; Champion, HC; Doherty, PC; Hellstrom, WJ; Kadowitz, PJ; Wang, R | 1 |
| Kim, SC; Lee, MY; Lee, SK; Seo, KK; Song, ES | 1 |
| Moncada Iribarren, I; Sáenz de Tejada, I | 1 |
| Britanico, J; Galea, G; Nicolis, C; Vapnek, JM; Zaslau, S | 1 |
| Az-Ma, T; Saeki, N; Yuge, O | 1 |
| Baniel, J; Israilov, S; Livne, P; Segenreich, E; Shmueli, J; Simon, D | 1 |
| Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Segenreich, E; Shmueli, J | 1 |
| Kim, SC; Lee, SW; Park, BD; Seo, KK | 1 |
| Chew, KK | 1 |
| Altinok, D; Baçar, H; Baçar, MM; Batislam, E; Yilmaz, E | 1 |
| Ledda, A | 1 |
| Bassas, L; Jurado, C; Pomerol, JM; Rajmil, O; Ribé, N | 1 |
| Aguiar, W; Andrade, E; Claro, Jde A; de Aboim, JE; Maríngolo, M; Nardozza Júnior, A; Nogueira, M; Srougi, M | 1 |
| Nissenkorn, I; Richter, S; Ringel, A; Shalev, M; Vardi, Y | 1 |
| Atan, A; Başar, MM; Bozdoğan, O; Sahin, M | 1 |
| Boiteau, F; Boyer, F; Dizien, O; Laffont, I; Lebib Ben Achour, S | 1 |
| Athanasopoulos, A; Barbalias, G; Gyftopoulos, K; Perimenis, P | 1 |
| Davis, H; Kurowski, S; Parker, E; Salisbury, B; Vemulapalli, R | 1 |
| Elhanbly, S; Elmogy, M; Hegazy, A; Niederberger, C; Ross, L; Schoor, R | 1 |
| Lee, KL; Lue, TF | 1 |
| Baniel, J; Engelstein, D; Israilov, S; Livne, PM; Niv, E; Segenreich, E; Shmueli, J | 1 |
| Thomas, JA | 1 |
| Apostolidis, A; Bekas, M; Hatzichristou, D; Hatzimouratidis, K; Tzortzis, V; Yannakoyorgos, K | 1 |
| Asuar Aydillo, S | 1 |
| Cosgrove, D; Jain, A; Kasyan, A; Monga, M; Rajasekaran, M; Wilkes, N; Zupkas, P | 1 |
| McVary, KT; Yap, RL | 1 |
| Cestari, A; Deho', F; Guazzoni, G; Montorsi, F; Rigatti, P; Salonia, A; Stief, C | 1 |
| Erdei, E; Papp, G | 1 |
| Ching, HL; Earle, CM; Stuckey, BG; Wisniewski, ZS | 1 |
| Görich, J; Heindel, W; Krämer, SC; Oertel, F; Scheld, H | 1 |
| Agarwal, A; Ausmundson, S; Klein, E; Lakin, MM; Montague, DK; Raina, R; Thukral, M; Zippe, CD | 1 |
| Ghanem, HM; Kamel, II; Mousa, AA; Salem, A; Shamloul, R | 1 |
| Ghanem, HM; Hamed, HA; Kamel, II; Moemen, MN; Shamloul, RM | 1 |
| Agarwal, A; Ausmundson, S; Lakin, MM; Montague, DK; Raina, R; Zippe, CD | 1 |
| Gabouev, AI; Jonas, U; Mertsching, H; Pilatz, A; Schlote, N; Schultheiss, D; Sohn, M; Stief, CG; Wefer, J | 1 |
| Goldstein, I; Lewis, JH; Rosen, R | 1 |
| Gabouev, AI; Jonas, U; Mertsching, H; Pilatz, A; Schlote, N; Schultheiss, D; Stief, CG | 1 |
| Hatzichristou, DG; Hatzimouratidis, K | 1 |
| Blachar, A; Copel, L; Katz, R; Sheiman, RG; Sosna, J | 1 |
| Craven, BC; Gordon, M; Hassouna, M; Kaiser, A; Lanctôt, LK; MacMillan, DH; Mittmann, N; Raynard, W; Tarride, JE | 1 |
| Mulhall, JP; Ohebshalom, M | 1 |
| Ausmundson, SJ; Butler, RS; Jones, JS; Lakin, MM; Lane, BR; Lane, BZ; Zippe, CD | 1 |
| Athanasopoulos, A; Gyftopoulos, K; Kartsanis, G; Konstantinopoulos, A; Liatsikos, E; Perimeni, PP; Perimenis, P | 1 |
| Hsieh, ML; Huang, ST | 1 |
| Barry, JM | 1 |
| Dai, YT; Hoang, A; Howard, GE; Lin, HC; Wang, R; Yuan, JH | 1 |
| Goldstein, I | 1 |
| Mostafa, T; Salem, H | 1 |
| Balk, E; Bennett, NE; Hsiao, W; Mulhall, JP; Narus, J; Nelson, CJ; Tal, R | 1 |
| Astier, A; Deffaux, C; Eychenne, N; Paul, M; Vieillard, V; Yiou, R | 1 |
| Ahn, JS; Choo, SH; Han, DH; Kim, JJ; Lee, SW; Sung, HH | 1 |
| Benbouzid, R; Enjalbert, M; Hadiji, N; Leblond, C; Mieusset, R; Previnaire, JG; Soler, JM | 1 |
| Pezzoni, F; Scroppo, FI | 1 |
| Bonan, I; Chéhensse, C; Chochina, L; Damphousse, M; Giuliano, F; Manunta, A; Naudet, F | 1 |
| Grisk, O; Juretzko, A; Kühn, JP; Mahlke, C; Mensel, B; Schreiber, A; Steinbach, A | 1 |
| Duan, T; Kong, R; Song, R; Xiang, D; Xu, D; Zhang, J | 1 |
| Elena, BW; Graham, BA; Haritha, P; Wayne, HJG; Zachary, M | 1 |
29 review(s) available for papaverine and alprostadil
| Article | Year |
|---|---|
[Bladder dysfunction and sexual dysfunction and their management in patients with MS disease].
Topics: Alprostadil; Erectile Dysfunction; Female; Humans; Male; Multiple Sclerosis; Papaverine; Sexual Dysfunction, Physiological; Urinary Bladder, Neurogenic; Urination Disorders; Urodynamics | 1992 |
[Impotence of vascular origin. Techniques of exploration and therapeutic orientations].
Topics: Adult; Alprostadil; Angiography; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penile Prosthesis; Penis; Plethysmography; Ultrasonography | 1992 |
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prospective Studies | 1992 |
[A year in male impotence].
Topics: Age Factors; Alprostadil; Animals; Castration; Clinical Trials as Topic; Disease Models, Animal; Dogs; Erectile Dysfunction; Hemodynamics; Humans; Incidence; Male; Neurophysiology; Neurotransmitter Agents; Papaverine; Penile Erection; Penile Prosthesis; Phentolamine; Plethysmography; Prevalence; Suction; Ultrasonography; Vascular Surgical Procedures | 1991 |
[Endocavernous drug infusions revisited].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penile Erection; Penis; Phentolamine; Vasoactive Intestinal Peptide; Vasodilator Agents; Yohimbine | 1991 |
Radionuclide studies in impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Radionuclide Imaging; Xenon Radioisotopes | 1991 |
[Treatment of impotence].
Topics: Alprostadil; Androgens; Attitude to Health; Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Sex Counseling; Trazodone; Vasoactive Intestinal Peptide; Yohimbine | 1994 |
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Retrospective Studies; Self Administration | 1993 |
[Long-term results of the treatment with intracavernous injection of vasoactive drugs].
Topics: Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Papaverine; Penis; Time Factors; Vasodilator Agents | 1996 |
[Drug treatment of sexual disorders in men].
Topics: Alprostadil; Humans; Impotence, Vasculogenic; Injections; Male; Papaverine; Penile Erection; Penis; Phentolamine; Sexual Dysfunction, Physiological; Sympatholytics; Vasodilator Agents | 1996 |
Drugs for the treatment of impotence.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Administration, Oral; Administration, Topical; Adrenergic alpha-Antagonists; Aged; Alprostadil; Dinoprostone; Enzyme Activation; Enzyme Inhibitors; Erectile Dysfunction; Humans; Male; Neurotransmitter Agents; Papaverine; Penile Erection; Phosphodiesterase Inhibitors; Selective Serotonin Reuptake Inhibitors; Testosterone; Vasodilator Agents | 1997 |
New developments in self-injection therapy for erectile dysfunction.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Chlorpromazine; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Injections; Male; Moxisylyte; Papaverine; Patient Satisfaction; Phentolamine; Self Administration; Sympatholytics; Treatment Outcome; Vasoactive Intestinal Peptide; Vasodilator Agents | 1998 |
[Treatment for impotence].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Administration, Oral; Alprostadil; Erectile Dysfunction; Humans; Injections; Papaverine; Penile Prosthesis; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1998 |
[Pharmacotherapy of erectile dysfunction].
Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Treatment Outcome; Vasodilator Agents | 1999 |
Pharmacological treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Male; Muscle Relaxation; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 1999 |
Intracavernosal injection therapy. Does it still have a role in erectile dysfunction?
Topics: Adult; Aged; Alprostadil; Australia; Erectile Dysfunction; Humans; Injections, Intralesional; Male; Middle Aged; Papaverine; Patient Satisfaction; Prognosis; Treatment Outcome | 2001 |
Erectile dysfunction: intracavernous treatment.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phentolamine; Vasodilator Agents | 2000 |
Pharmacotherapy for erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Nitric Oxide Donors; Papaverine; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones | 2000 |
Pharmacological aspects of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Apomorphine; Drug Interactions; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Testosterone; Trazodone | 2002 |
Topical agents and erectile dysfunction: is there a place?
Topics: Administration, Topical; Alprostadil; Erectile Dysfunction; Humans; Male; Minoxidil; Nitroglycerin; Papaverine; Testosterone | 2002 |
Pharmacological management of erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Carbolines; Drug Combinations; Erectile Dysfunction; Humans; Imidazoles; Injections; Male; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Tadalafil; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
[Conservative treatment of erectile dysfunction].
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Alprostadil; Apomorphine; Dopamine Agonists; Erectile Dysfunction; Humans; Imidazoles; Impotence, Vasculogenic; Injections; Male; Nitric Oxide; Papaverine; Phosphodiesterase Inhibitors; Piperazines; Psychotherapy; Purines; Sildenafil Citrate; Sulfones; Triazines; Vacuum; Vardenafil Dihydrochloride; Vasodilator Agents | 2003 |
[Non-occlusive mesenteric ischemia].
Topics: Abdominal Pain; Age Factors; Aged; Alprostadil; Angiography; Cardiac Surgical Procedures; Contraindications; Diagnosis, Differential; Female; Humans; Infusions, Intra-Arterial; Ischemia; Male; Mesentery; Papaverine; Phosphodiesterase Inhibitors; Postoperative Complications; Risk Factors; Tomography, Spiral Computed; Tomography, X-Ray Computed; Vasodilator Agents | 2003 |
Erectile dysfunction in primary care.
Topics: Aftercare; Alprostadil; Causality; Communication; Diagnosis, Differential; Erectile Dysfunction; Humans; Male; Medical History Taking; Nurse Practitioners; Nurse-Patient Relations; Nursing Assessment; Papaverine; Patient Education as Topic; Patient Selection; Penile Prosthesis; Phosphodiesterase Inhibitors; Physical Examination; Piperazines; Primary Health Care; Purines; Sex Counseling; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2004 |
A comparative review of the options for treatment of erectile dysfunction: which treatment for which patient?
Topics: Administration, Oral; Alprostadil; Apomorphine; Carbolines; Constriction; Contraindications; Dopamine Agonists; Drug Combinations; Enzyme Inhibitors; Erectile Dysfunction; Humans; Imidazoles; Male; Papaverine; Patient Satisfaction; Penile Prosthesis; Penis; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Purines; Regional Blood Flow; Sildenafil Citrate; Sulfones; Tadalafil; Treatment Failure; Triazines; Vardenafil Dihydrochloride; Vasodilator Agents | 2005 |
Transdermal and topical pharmacotherapy for male sexual dysfunction.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Androgens; Animals; Erectile Dysfunction; Humans; Hypogonadism; Iontophoresis; Male; MEDLINE; Papaverine; Penile Induration; Pharmaceutical Preparations; Phosphodiesterase Inhibitors; Sexual Dysfunction, Physiological; Testosterone; Urethra; Vasodilator Agents; Verapamil | 2005 |
Treating erectile dysfunction in renal transplant recipients.
Topics: Alprostadil; Erectile Dysfunction; Humans; Kidney Transplantation; Male; Papaverine; Penile Erection; Penile Prosthesis; Phosphodiesterase Inhibitors; Psychotherapy; Vasodilator Agents | 2007 |
Intracavernous Injections in Spinal Cord Injured Men With Erectile Dysfunction, a Systematic Review and Meta-Analysis.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Penile Erection; Prospective Studies; Retrospective Studies; Spinal Cord Injuries; Vasodilator Agents | 2016 |
Current status of intracavernosal injection therapy in erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Vasodilator Agents | 2023 |
38 trial(s) available for papaverine and alprostadil
| Article | Year |
|---|---|
Objective double-blind evaluation of erectile function with intracorporeal papaverine in combination with phentolamine and/or prostaglandin E1.
Topics: Alprostadil; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine; Prospective Studies; Time Factors | 1992 |
Comparative value of prostaglandin E1 and papaverine in treatment of erectile failure: double-blind crossover study among Egyptian patients.
Topics: Alprostadil; Double-Blind Method; Egypt; Erectile Dysfunction; Humans; Male; Papaverine; Prospective Studies | 1992 |
[Prospective study of the effectiveness and side effects of intracavernous prostaglandin E1 versus papaverine or papaverine phentolamine in the diagnosis and treatment of erection dysfunction. Review of the literature].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prospective Studies | 1992 |
Double-blind, cross-over study comparing prostaglandin E1 and papaverine in patients with vasculogenic impotence.
Topics: Alprostadil; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Vascular Diseases | 1991 |
Prostaglandin E1 therapy for impotence, comparison with papaverine.
Topics: Adult; Aged; Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Single-Blind Method | 1990 |
A prospective double-blind trial of intracorporeal papaverine versus prostaglandin E1 in the treatment of impotence.
Topics: Adult; Aged; Alprostadil; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Prospective Studies; Random Allocation | 1989 |
Prostaglandin E1 versus phentolamine/papaverine for the treatment of erectile impotence: a double-blind comparison.
Topics: Alprostadil; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Phentolamine | 1989 |
Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction.
Topics: Alprostadil; Clinical Trials as Topic; Double-Blind Method; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine | 1988 |
Papaverine-phentolamine and prostaglandin E1 versus papaverine-phentolamine alone for intracorporeal injection therapy: a clinical double-blind study.
Topics: Adult; Aged; Alprostadil; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine | 1995 |
Comparison of a mixture of papaverine, phentolamine and prostaglandin E1 with other intracavernous injections.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Follow-Up Studies; Humans; Injections; Male; Papaverine; Penile Erection; Penis; Phentolamine; Priapism; Self Administration | 1994 |
Intracavernous calcitonin gene-related peptide plus prostaglandin E1: possible alternative to penile implants in selected patients.
Topics: Alprostadil; Calcitonin Gene-Related Peptide; Drug Combinations; Humans; Impotence, Vasculogenic; Male; Papaverine; Penile Erection; Penile Prosthesis; Phentolamine | 1994 |
Intracavernous self-injection pharmacotherapy program: analysis of results and complications.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections; Male; Middle Aged; Papaverine; Penis; Phentolamine; Priapism; Self Administration | 1994 |
Sodium bicarbonate alleviates penile pain induced by intracavernous injections for erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Bicarbonates; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Incidence; Injections; Male; Middle Aged; Pain; Papaverine; Penile Erection; Penis; Phentolamine; Sodium; Sodium Bicarbonate | 1993 |
Intracavernous pharmacotherapy for impotence: selection of appropriate agent and dose.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Retrospective Studies; Self Administration | 1993 |
Prostaglandin E1 versus mixture of prostaglandin E1, papaverine and phentolamine in nonresponders to high papaverine plus phentolamine doses.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Prospective Studies; Vasodilator Agents | 1996 |
Minimally invasive therapies in the treatment of erectile dysfunction in anticoagulated cases: a study of satisfaction and safety.
Topics: Alprostadil; Anticoagulants; Cross-Over Studies; Humans; Impotence, Vasculogenic; Male; Papaverine; Patient Satisfaction; Phentolamine; Prospective Studies; Safety; Self Administration; Surveys and Questionnaires; Vacuum; Vasodilator Agents; Warfarin | 1996 |
Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Vasodilator Agents | 1996 |
Determinants of satisfactory rigidity after intracavernosal injection with prostaglandin E1 in men with erectile failure.
Topics: Adrenergic alpha-Antagonists; Aging; Alprostadil; Drug Combinations; Erectile Dysfunction; Gonadal Steroid Hormones; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Plethysmography; Smoking; Testosterone; Vasodilator Agents | 1996 |
Nonsurgical treatment of cavernosal venous leakage.
Topics: Adult; Aged; Alprostadil; Constriction; Drug Therapy, Combination; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Phentolamine; Prospective Studies; Severity of Illness Index; Vacuum; Vasodilator Agents | 1997 |
Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Patient Satisfaction; Phentolamine; Vasodilator Agents | 1997 |
Intracavernosal drug-induced erection therapy versus external vacuum devices in the treatment of erectile dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Attitude to Health; Coitus; Cross-Over Studies; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Patient Satisfaction; Penile Erection; Phentolamine; Prospective Studies; Self Care; Treatment Outcome; Urology; Vacuum; Vasodilator Agents | 1997 |
Intracavernosal forskolin: role in management of vasculogenic impotence resistant to standard 3-agent pharmacotherapy.
Topics: Alprostadil; Animals; Cells, Cultured; Colforsin; Cyclic AMP; Dose-Response Relationship, Drug; Drug Resistance; Drug Therapy, Combination; Humans; Impotence, Vasculogenic; Injections; Male; Papaverine; Penis; Phentolamine; Rabbits; Vasodilator Agents | 1997 |
Atropine role in the pharmacological erection test: study of 228 patients.
Topics: Adult; Aged; Alprostadil; Atropine; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Risk Factors; Vasodilator Agents | 1997 |
Papaverine plus prostaglandin E1 versus prostaglandin E1 alone for intracorporeal injection therapy.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Middle Aged; Pain; Papaverine; Treatment Outcome | 1998 |
Transurethral alprostadil as therapy for patients who withdrew from or failed prior intracavernous injection therapy.
Topics: Administration, Topical; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Coitus; Double-Blind Method; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Pain; Papaverine; Patient Satisfaction; Penile Erection; Penis; Phentolamine; Placebos; Retrospective Studies; Treatment Failure; Urethra; Vasodilator Agents | 1998 |
Accumulation of platelets as a key mechanism of human erection.
Topics: Adult; Aged; Alprostadil; Blood Platelets; Cell Survival; Humans; Indium Radioisotopes; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Platelet Count; Radionuclide Imaging; Vasodilator Agents | 1998 |
Combination therapy using oral alpha-blockers and intracavernosal injection in men with erectile dysfunction.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Doxazosin; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentolamine; Pilot Projects; Vasodilator Agents | 1998 |
Transcranial Doppler pattern after intracarotid papaverine and prostaglandin E1 incorporated in lipid microsphere in patients with vasospasm.
Topics: Alprostadil; Brain; Carotid Arteries; Humans; Injections, Intra-Arterial; Ischemic Attack, Transient; Microspheres; Papaverine; Treatment Outcome; Ultrasonography, Doppler, Transcranial; Vasodilator Agents | 1998 |
Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test.
Topics: Adult; Alprostadil; Constriction, Pathologic; Erectile Dysfunction; Hemodynamics; Humans; Impotence, Vasculogenic; Injections; Male; Mass Screening; Middle Aged; Papaverine; Penis; Phentolamine; Pressure; Prospective Studies; Regional Blood Flow; Sensitivity and Specificity; Veins | 1999 |
Treatment of intracorporeal injection nonresponse with sildenafil alone or in combination with triple agent intracorporeal injection therapy.
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Middle Aged; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Vasodilator Agents | 1999 |
Three-year outcome of a progressive treatment program for erectile dysfunction with intracavernous injections of vasoactive drugs.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Hemorrhage; Humans; Male; Middle Aged; Pain; Papaverine; Phentolamine; Priapism; Treatment Outcome | 2000 |
Risk factors for an early increase in dose of vasoactive agents for intracavernous pharmacotherapy.
Topics: Adult; Aged; Alprostadil; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Injections, Intralesional; Male; Middle Aged; Papaverine; Phentolamine; Risk Assessment; Treatment Outcome; Vasodilator Agents | 2000 |
Sildenafil citrate for penile hemodynamic determination: an alternative to intracavernosal agents in Doppler ultrasound evaluation of erectile dysfunction.
Topics: Adult; Alprostadil; Erectile Dysfunction; Hemodynamics; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Penis; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Ultrasonography | 2001 |
[Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Vasodilator Agents | 2001 |
[Intracavernous injections in the treatment of erectile dysfunction in spinal cord injured patients: experience with 36 patients].
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Moxisylyte; Papaverine; Patient Satisfaction; Spinal Cord Injuries; Vasodilator Agents | 2001 |
The value of penile duplex in the prediction of intracavernous drug-induced priapism.
Topics: Alprostadil; Antihypertensive Agents; Erectile Dysfunction; Humans; Ischemia; Male; Middle Aged; Papaverine; Phentolamine; Predictive Value of Tests; Priapism; Regional Blood Flow; Sensitivity and Specificity; Ultrasonography, Doppler, Color; Vasodilator Agents | 2004 |
Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances.
Topics: Adult; Alprostadil; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Injections, Intralesional; Male; Middle Aged; Papaverine; Penis; Phentolamine; Self Administration; Ultrasonography, Doppler, Duplex; Vasodilator Agents | 2004 |
Iloprost, Prostaglandin E1, and Papaverine Relax Human Mesenteric Arteries With Similar Potency.
Topics: Aged; Alprostadil; Endothelin-1; Female; Humans; Iloprost; Male; Mesenteric Arteries; Mesenteric Ischemia; Middle Aged; Organ Culture Techniques; Papaverine; rho-Associated Kinases; Vasodilation | 2017 |
165 other study(ies) available for papaverine and alprostadil
| Article | Year |
|---|---|
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Drugs for impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Minoxidil; Nitroglycerin; Papaverine | 1992 |
A comparative study with intracavernous injection of prostaglandin E1 versus papaverine for the diagnostic assessment of erectile impotence.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Time Factors | 1992 |
Intracavernous self-injection therapy for the treatment of erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Self Administration | 1992 |
[Impotence: introductory notes].
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penile Prosthesis; Phenoxybenzamine; Phentolamine | 1992 |
Venous surgery in veno-occlusive dysfunction: long-time results after deep dorsal vein resection.
Topics: Adult; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penis; Postoperative Complications; Time Factors; Treatment Outcome; Vascular Diseases; Veins | 1992 |
[Intracavernous infusion of drugs].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Ketanserin; Male; Papaverine; Penis; Phentolamine; Vasoactive Intestinal Peptide; Yohimbine | 1992 |
Penile revascularization in nonresponders to intracavernous injections using a modified microsurgical technique.
Topics: Alprostadil; Arteriovenous Shunt, Surgical; Erectile Dysfunction; Humans; Male; Microsurgery; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine | 1992 |
Treatment of erectile impotence in renal transplant patients with intracavernosal vasoactive drugs.
Topics: Alprostadil; Erectile Dysfunction; Estradiol; Follicle Stimulating Hormone; Humans; Kidney Transplantation; Luteinizing Hormone; Male; Middle Aged; Papaverine; Penile Erection; Prolactin; Renal Dialysis; Retrospective Studies; Testosterone; Vasoconstrictor Agents | 1992 |
Intracavernous pressure as an experimental index in a rat model for the evaluation of penile erection.
Topics: Alprostadil; Animals; Clonidine; Male; Models, Biological; Papaverine; Penile Erection; Pressure; Rats; Rats, Inbred Strains | 1992 |
Patient satisfaction with pharmacologic erection program.
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Patient Satisfaction; Penile Erection; Phentolamine; Self Administration; Self Concept | 1992 |
Comparison of effects following the intracorporeal injection of papaverine and prostaglandin E1.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Erectile Dysfunction; Humans; Injections, Intramuscular; Male; Middle Aged; Papaverine; Penile Erection; Time Factors | 1992 |
Penile pharmacological duplex ultrasonography: a dose-effect study comparing papaverine, papaverine/phentolamine and prostaglandin E1.
Topics: Aged; Alprostadil; Blood Flow Velocity; Dose-Response Relationship, Drug; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Phentolamine; Ultrasonography | 1992 |
Intracavernosal injection of prostaglandin E1 as an alternative for papaverine in penile angiography.
Topics: Alprostadil; Angiography; Angiography, Digital Subtraction; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1992 |
The role of intracavernosal vasoactive agents to overcome impotence due to spinal cord injury.
Topics: Adult; Alprostadil; Blood Pressure; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentolamine; Self Administration; Spinal Cord Injuries; Vasodilator Agents | 1992 |
An improved vasoactive drug combination for a pharmacological erection program.
Topics: Adult; Aged; Alprostadil; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine | 1991 |
Quantitative evaluation of the penile vascular status by means of the 99mTc-penogram in conjunction with either papaverine or prostaglandin E1 in the anaesthetised baboon model.
Topics: Alprostadil; Anesthesia; Animals; Male; Papaverine; Papio; Penis; Radionuclide Imaging; Regional Blood Flow; Technetium | 1991 |
[Non-surgical treatment of impotence].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Self Administration | 1991 |
[Intracavernous pharmacotherapy for treatment and evaluation of impotence].
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Self Administration | 1991 |
Histopathological change of corpora cavernosa after long-term intracavernous injection.
Topics: Alprostadil; Animals; Dose-Response Relationship, Drug; Erectile Dysfunction; Fibrosis; Injections; Macaca fascicularis; Male; Microscopy, Electron; Papaverine; Penile Erection; Penis; Time Factors | 1991 |
Treatment of pharmacological priapism with phenylephrine.
Topics: Adult; Alprostadil; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Phenylephrine; Priapism; Remission Induction; Time Factors | 1991 |
Investigating male sexual dysfunction. Cavernosograms and penile flow studies.
Topics: Alprostadil; Arterial Occlusive Diseases; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Physical Examination; Vascular Diseases | 1991 |
Calcitonin-gene-related peptide: a possible role in human penile erection and its therapeutic application in impotent patients.
Topics: Adult; Aged; Alprostadil; Calcitonin Gene-Related Peptide; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine | 1991 |
Intracorporeal injections for the treatment of impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1991 |
[Neurotransmitters of penile erection other than vasoactive intestinal polypeptide. Physiologic data and therapeutic consequences].
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Neurotransmitter Agents; Papaverine; Penile Erection; Priapism; Receptors, Adrenergic, alpha; Trazodone; Vasoactive Intestinal Peptide; Yohimbine | 1990 |
Intracavernous injection of prostaglandin E1 in combination with papaverine: enhanced effectiveness in comparison with papaverine plus phentolamine and prostaglandin E1 alone.
Topics: Adult; Alprostadil; Drug Evaluation; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Reaction Time | 1991 |
Comparison of the effects of papaverine versus prostaglandin E1 on penile blood flow by color duplex sonography.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penis; Regional Blood Flow; Sensitivity and Specificity; Ultrasonography | 1991 |
[Diabetic impotence].
Topics: Alprostadil; Diabetes Complications; Diabetic Angiopathies; Diabetic Neuropathies; Diagnosis, Differential; Erectile Dysfunction; Humans; Kallikreins; Male; Papaverine; Penile Prosthesis; Psychotherapy; Thiamine | 1991 |
The combined use of sex therapy and intrapenile injections in the treatment of impotence.
Topics: Adult; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Female; Humans; Injections; Male; Middle Aged; Papaverine; Patient Acceptance of Health Care; Penis; Phentolamine; Prognosis; Sex Counseling | 1990 |
[Pharmacocavernosometry and pharmacocavernosography in erectile dysfunction].
Topics: Alprostadil; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Phlebography; Ultrasonography; Veins; Venous Insufficiency | 1990 |
[Erectile dysfunction of male spinal cord injury patients].
Topics: Adult; Alprostadil; Ejaculation; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Spinal Cord Injuries | 1990 |
[Prostaglandin E1 injection in erectile dysfunction. Current diagnostic and therapeutic possibilities].
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Induration; Priapism; Testis | 1990 |
Intracavernous injections for impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Self Administration | 1990 |
Preoperative assessment of penile curvature by artificial erection.
Topics: Alprostadil; Humans; Male; Papaverine; Penile Diseases; Penile Erection | 1990 |
Quantitation of pharmacologically-induced penile erections: the value of radionuclide phallography in the objective evaluation of erectile haemodynamics.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Erythrocytes; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Radionuclide Imaging; Technetium | 1990 |
[Intracavernous injection of vasoactive drugs for treating erectile impotence].
Topics: Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine | 1988 |
Intracavernosal injection of pharmacological agents in the diagnosis and treatment of impotence.
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection | 1989 |
Electric field stimulation alters the outputs of prostaglandins from isolated rat urinary bladder preparations. Influences of papaverine and tetradotoxin.
Topics: Alprostadil; Animals; Dinoprost; Dinoprostone; Electric Stimulation; Female; In Vitro Techniques; Muscle Contraction; Papaverine; Prostaglandins; Rats; Rats, Inbred Strains; Synaptic Transmission; Tetrodotoxin; Urinary Bladder | 1989 |
[Comment on the contribution by H. Porst and H. van Ahlen. Drug-induced priapism--a report of experiences with 101 cases. Urologe [A] (1989) 28: 84-7].
Topics: Alprostadil; Humans; Male; Papaverine; Phentolamine; Priapism; Risk Factors | 1989 |
Vascular insufficiency: a significant factor in impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Male; Papaverine; Penile Prosthesis; Penis; Phentolamine | 1989 |
Comparison of penile vascular effect induced by intracavernous injection of papaverine and prostaglandin E1.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Blood Flow Velocity; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1989 |
[Prostaglandin E1 in erectile dysfunction].
Topics: Alprostadil; Blood Flow Velocity; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Ultrasonography | 1989 |
The pH analysis of papaverine-phentolamine and prostaglandin E1 for pharmacologic erection.
Topics: Alprostadil; Buffers; Chemical Phenomena; Chemistry; Drug Combinations; Drug Stability; Erectile Dysfunction; Humans; Hydrogen-Ion Concentration; Male; Papaverine; Penile Erection; Phentolamine | 1989 |
Local and systemic effects of chronic intracavernous injection of papaverine, prostaglandin E1, and saline in primates.
Topics: Alprostadil; Animals; Liver Function Tests; Macaca nemestrina; Male; Microscopy, Electron; Papaverine; Penile Erection; Penis; Sodium Chloride; Time Factors | 1989 |
[3 years' experience with intracavernous auto-injection therapy].
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine | 1989 |
Pharmacological consideration of intracavernous drug injection in the treatment of impotence.
Topics: Adrenergic beta-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis | 1988 |
Use of prostaglandin E1 for papaverine-failed erections.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis | 1989 |
Tumor differentiation--application of prostaglandins in the treatment of neuroblastoma.
Topics: Abdominal Neoplasms; Alprostadil; Animals; Blood Coagulation Factors; Cell Differentiation; Cell Division; Cells, Cultured; Child; Child, Preschool; Cyclic AMP; Drug Evaluation; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female; Humans; Male; Mice; Neuroblastoma; Papaverine; Platelet Activating Factor; Prostaglandin D2; Prostaglandins D; Prostaglandins E | 1985 |
Enhanced intranuclear expression of measles virus following exposure of persistently infected cells to cyclic AMP.
Topics: Adenylyl Cyclases; Alprostadil; Antigens, Viral; Cell Line; Cell Transformation, Viral; Cyclic AMP; Fluorescent Antibody Technique; Humans; Measles virus; Microscopy, Electron; Papaverine; Prostaglandins E; Serotonin | 1985 |
[Disorders of erectile potency in diabetes mellitus].
Topics: Aged; Alprostadil; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Diabetic Neuropathies; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Ultrasonography | 1988 |
[Value of prostaglandin El in the diagnosis of erectile dysfunction in comparison with papaverine and papaverine/phentolamine in 61 patients with erectile dysfunction].
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Regional Blood Flow; Ultrasonography | 1988 |
Neuroblastoma: incomplete differentiation on the way to maturation or morphological alteration resembling maturity?
Topics: Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Humans; Neuroblastoma; Papaverine | 1988 |
The platelet strip. I. A low-fibrin contractile model of thrombin-activated platelets.
Topics: Alprostadil; Blood Platelets; Clot Retraction; Epinephrine; Epoprostenol; Fibrin; Humans; In Vitro Techniques; Kinetics; Microscopy, Electron; Models, Biological; Nylons; Papaverine; Platelet Aggregation; Prostaglandins E; Thrombin | 1985 |
The effectiveness of local injections of vasodilating agents to produce vasodilation in subcutaneous tissue in rabbits.
Topics: Alprostadil; Animals; Antipyrine; Dose-Response Relationship, Drug; Histamine; Injections, Subcutaneous; Iodine Radioisotopes; Methods; Microcirculation; Nitroprusside; Papaverine; Prostaglandins E; Rabbits; Regional Blood Flow; Vasodilation; Vasodilator Agents; Verapamil; Xenon Radioisotopes | 1985 |
[Intra-aortic PGE1 infusion combined with anti-malignant chemotherapy in the treatment of advanced neuroblastoma].
Topics: Administration, Oral; Adrenal Gland Neoplasms; Alprostadil; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cyclophosphamide; Doxorubicin; Female; Humans; Infusions, Intra-Arterial; Male; Neuroblastoma; Papaverine; Prostaglandins E; Vincristine | 1985 |
Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators.
Topics: Alprostadil; Animals; Blood Pressure; Carbon Tetrachloride; Cytochalasin B; In Vitro Techniques; Isoproterenol; Liver Cirrhosis; Magnesium Sulfate; Male; Nitroprusside; Papaverine; Perfusion; Portal System; Portal Vein; Rats; Rats, Inbred Strains; Vascular Resistance; Vasodilator Agents | 1985 |
The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
Topics: Alprostadil; Blood Platelets; Cyclic AMP; Humans; Papaverine; Platelet Aggregation; Prostaglandins E; Pyridoxal Phosphate; Theophylline; Thrombin | 1984 |
Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
Topics: Adenylyl Cyclases; Adult; Alprostadil; Blood Platelets; Cyclic AMP; Dipyridamole; Female; Humans; Hydantoins; Male; Middle Aged; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandins E; Pyridoxal Phosphate; Theophylline | 1984 |
Effects of alpha 2-adrenoceptor agonists and of related compounds on aggregation of, and on adenylate cyclase activity in, human platelets.
Topics: Adenosine Diphosphate; Adenylyl Cyclases; Adrenergic alpha-Agonists; Adult; Alprostadil; Blood Platelets; Cyclic AMP; Drug Interactions; Epinephrine; Humans; In Vitro Techniques; Papaverine; Platelet Aggregation; Prostaglandins E | 1984 |
The lack of correlation between inhibition of aggregation and cAMP levels with canine platelets.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Animals; Arachidonic Acids; Cyclic AMP; Depression, Chemical; Dogs; Epinephrine; Female; Male; Papaverine; Phosphodiesterase Inhibitors; Platelet Aggregation; Prostaglandins E; Theophylline | 1982 |
Rapid activation of cAMP phosphodiesterase in rat platelets.
Topics: 1-Methyl-3-isobutylxanthine; 3',5'-Cyclic-AMP Phosphodiesterases; Alprostadil; Animals; Blood Platelets; Calcimycin; Calcium; Dipyridamole; Enzyme Activation; Epoprostenol; Indomethacin; Papaverine; Prostaglandins E; Protein Kinases; Rats | 1983 |
Pharmacological properties of platelet strips.
Topics: Adenosine Diphosphate; Alprostadil; Angiotensin II; Aorta; Blood Platelets; Humans; In Vitro Techniques; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Papaverine; Platelet Aggregation; Prostaglandins E; Serotonin; Sulfonamides; Time Factors | 1983 |
Intra-aortic prostaglandin E1 infusion in maturation of neuroblastoma.
Topics: Abdominal Neoplasms; Alprostadil; Aorta; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Humans; Infusions, Intra-Arterial; Male; Neuroblastoma; Papaverine; Prostaglandins E | 1982 |
Regression and differentiation of neuroblastoma tumors in mice treated with differentiating agents--prostaglandin E1 and a phosphodiesterase inhibitor, RO 20-1724.
Topics: 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Alprostadil; Animals; Cell Differentiation; Drug Therapy, Combination; Female; Imidazoles; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Neuroblastoma; Papaverine; Prostaglandins E | 1982 |
[Effects of 16,16-dimethyl-trans-delta 2-PGE1 methyl ester (ONO-802) on uterine motility (author's transl)].
Topics: Alprostadil; Animals; Cricetinae; Dose-Response Relationship, Drug; Female; Papaverine; Pregnancy; Prostaglandins; Prostaglandins E, Synthetic; Rats; Rats, Inbred Strains; Uterine Contraction; Verapamil | 1981 |
Effects of prostaglandin E1, and papaverine on non-neurogenic and neurogenic contraction of the isolated rabbit erectile tissue.
Topics: Alprostadil; Animals; Dose-Response Relationship, Drug; Ethylmaleimide; Male; Muscle Contraction; Muscle, Smooth; Papaverine; Penile Erection; Rabbits; Time Factors | 1995 |
Intracorporeal phenylephrine in the treatment of priapism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alprostadil; Blood Pressure; Erectile Dysfunction; Heart Rate; Humans; Injections; Male; Papaverine; Parasympatholytics; Phentolamine; Phenylephrine; Priapism; Prospective Studies; Time Factors; Vasodilator Agents | 1996 |
The clinical assessment of erectile dysfunction: a comparison of nocturnal penile tumescence monitoring and intracavernosal injections.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Sleep | 1995 |
[Clinical evaluation of intracavernous self-injection of vasoactive drugs for impotence: a long-term follow-up observation].
Topics: Adult; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Self Administration | 1994 |
A positive intracavernous injection test implies normal veno-occlusive but not necessarily normal arterial function: a hemodynamic study.
Topics: Adolescent; Adult; Aged; Alprostadil; Arteries; Blood Pressure; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Veins | 1994 |
Intracavernous injection of alprostadil for erectile dysfunction.
Topics: Alprostadil; Clinical Trials as Topic; Costs and Cost Analysis; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections, Intravenous; Male; Papaverine; Penis | 1995 |
Four-drug intracavernous therapy for impotence due to corporeal veno-occlusive dysfunction.
Topics: Alprostadil; Atropine; Drug Administration Schedule; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Peripheral Vascular Diseases; Phentolamine; Self Administration; Solutions | 1993 |
Intracavernous vasoactive pharmacotherapy: the impact of a new self-injection device.
Topics: Alprostadil; Atropine; Drug Combinations; Equipment Design; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Self Administration; Syringes | 1993 |
Effectiveness and safety of multidrug intracavernous therapy for vasculogenic impotence.
Topics: Alprostadil; Atropine; Drug Synergism; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections, Intravenous; Male; Papaverine; Penis; Phentolamine | 1993 |
Vascular interventions for impotence: lessons learned.
Topics: Adolescent; Adult; Aged; Alprostadil; Aneurysm; Aortic Aneurysm; Aortic Diseases; Arterial Occlusive Diseases; Brachial Artery; Follow-Up Studies; Humans; Iliac Artery; Impotence, Vasculogenic; Male; Microsurgery; Middle Aged; Papaverine; Penile Erection; Penis; Plethysmography; Prospective Studies; Radiography; Regional Blood Flow; Treatment Outcome | 1995 |
A possible approach to the suppression of side effects induced by PGE1.
Topics: Alprostadil; Animals; Atropine; Capillary Permeability; Gabexate; Guanidines; Guinea Pigs; Histamine; Ileum; Inflammation; Male; Muscle Contraction; Papaverine; Piperidines; Rats | 1995 |
Timing of penile color flow duplex ultrasonography using a triple drug mixture.
Topics: Alprostadil; Blood Flow Velocity; Humans; Impotence, Vasculogenic; Male; Masturbation; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Regional Blood Flow; Time Factors; Ultrasonography, Doppler, Color | 1995 |
Combining intracavernous injection and external vacuum as treatment for erectile dysfunction.
Topics: Aged; Alprostadil; Combined Modality Therapy; Erectile Dysfunction; Follow-Up Studies; Humans; Impotence, Vasculogenic; Male; Papaverine; Patient Satisfaction; Penile Erection; Time Factors; Vacuum | 1995 |
The rationale for prostaglandin E1 (alpha-alprostadil) in the management of male impotence.
Topics: Alprostadil; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Molsidomine; Moxisylyte; Papaverine; Penile Induration; Phentolamine | 1995 |
Relation of intracorporal pressure and end-diastolic velocity during duplex Doppler sonography in the evaluation of veno-occlusive dysfunction.
Topics: Adult; Aged; Alprostadil; Arteries; Blood Flow Velocity; Blood Pressure; Diastole; Fourier Analysis; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Ultrasonography, Doppler, Color; Ultrasonography, Doppler, Duplex; Veins | 1994 |
A new approach to the pharmacologic treatment of impotence.
Topics: Administration, Topical; Alprostadil; Blood Flow Velocity; Dose-Response Relationship, Drug; Humans; Impotence, Vasculogenic; Male; Nitroglycerin; Papaverine; Penis; Ultrasonography, Doppler; Veins | 1994 |
Management of pharmacologically induced prolonged penile erection with oral terbutaline in traumatic paraplegics.
Topics: Administration, Oral; Adult; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Paraplegia; Priapism; Terbutaline; Time Factors | 1994 |
Cyclic guanosine monophosphate mediates penile erection in the rat.
Topics: Alprostadil; Animals; Calcitonin Gene-Related Peptide; Cyclic AMP; Cyclic GMP; Dose-Response Relationship, Drug; Ethylmaleimide; Glutamates; Glutamic Acid; Male; Methylene Blue; Muscle Relaxation; N-Methylaspartate; Neurotransmitter Agents; Nitroprusside; Papaverine; Penile Erection; Rats; Rats, Sprague-Dawley; Vasoactive Intestinal Peptide | 1993 |
[Prostaglandin E1 in the treatment of erectile insufficiency. Comparison of efficacy and tolerance based on different etiologies].
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Retrospective Studies | 1994 |
Effects of papaverine and prostaglandin E1 on corpus cavernosum smooth muscle of arteriogenically and diabetically impotent men.
Topics: Alprostadil; Diabetic Angiopathies; Dose-Response Relationship, Drug; Humans; Impotence, Vasculogenic; Male; Middle Aged; Muscle Contraction; Muscle, Smooth; Papaverine; Penile Erection; Phenylephrine | 1994 |
Love and sex after 60: how to evaluate and treat the impotent older man. A roundtable discussion: Part 2.
Topics: Aged; Alprostadil; Erectile Dysfunction; Female; Heart Diseases; Humans; Male; Middle Aged; Papaverine; Penile Prosthesis; Phentolamine; Prostatectomy; Vacuum | 1994 |
Eliminating the strong pulmonary vasoconstriction caused by Euro-Collins solution.
Topics: Alprostadil; Animals; Constriction, Pathologic; Drug Combinations; Drug Interactions; Endothelium, Vascular; Epoprostenol; Hypertonic Solutions; Models, Biological; Nifedipine; Papaverine; Phenylacetates; Pulmonary Artery; Severity of Illness Index; Sulfonamides; Swine; Thromboxane A2; Thromboxanes; Vasoconstriction; Vasodilator Agents | 1994 |
[The pharmaco-erection test].
Topics: Alprostadil; Atropine; Diagnosis, Differential; Drug Combinations; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Papaverine; Penile Diseases; Penile Erection; Phentolamine; Vasodilator Agents | 1994 |
The change of penile blood thromboxane B2 and prostacyclin after intracavernous injection of vasoactive drugs for the treatment of arteriogenic impotence.
Topics: 6-Ketoprostaglandin F1 alpha; Adult; Aged; Alprostadil; Diabetes Complications; Epoprostenol; Erectile Dysfunction; Humans; Hypertension; Male; Middle Aged; Papaverine; Penis; Phentolamine; Radioimmunoassay; Thromboxane B2 | 1994 |
Clinical reliability of multi-drug intracavernous vasoactive pharmacotherapy for diabetic impotence.
Topics: Adult; Aged; Alprostadil; Atropine; Diabetes Complications; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Self Administration; Treatment Outcome | 1994 |
Reasons for patient drop-out from an intracavernous auto-injection programme for erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Patient Dropouts; Patient Satisfaction; Penile Diseases; Penile Erection; Phentolamine; Self Care; Treatment Refusal | 1994 |
What does duplex ultrasound add to sexual history, nocturnal penile tumescence and intracavernosal injection of smooth muscle relaxant, in the diagnosis of erectile dysfunction?
Topics: Adult; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Medical History Taking; Middle Aged; Papaverine; Penile Erection; Penis; Sexual Behavior; Sleep; Ultrasonography | 1993 |
Experience with intracavernosal tri-mixture for the management of neurogenic erectile dysfunction.
Topics: Adult; Alprostadil; Cost-Benefit Analysis; Drug Combinations; Drug Costs; Drug Monitoring; Drug Synergism; Erectile Dysfunction; Fibrosis; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Multiple Sclerosis; Papaverine; Patient Satisfaction; Penile Diseases; Penile Erection; Phentolamine; Priapism; Prostatectomy; Spinal Cord Injuries | 1994 |
Pharmacokinetics of vasoactive substances administered into the human corpus cavernosum.
Topics: Alprostadil; Humans; Injections; Male; Papaverine; Penis; Phentolamine | 1994 |
Experience with triple-drug therapy in a pharmacological erection program.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Cicatrix; Costs and Cost Analysis; Drug Combinations; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Priapism; Self Administration | 1993 |
Treatment of erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Penile Prosthesis; Phentolamine; Self Administration | 1993 |
Effect of multidose intracorporeal injection and audiovisual sexual stimulation in vasculogenic impotence.
Topics: Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Phentolamine; Photic Stimulation; Regional Blood Flow | 1993 |
[Complications of intracavernous pharmacologic infusion in impotence. Long-term results].
Topics: Adult; Aged; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Incidence; Male; Middle Aged; Papaverine; Penile Diseases; Phentolamine | 1993 |
Preoperative evaluation of erectile function with dynamic infusion cavernosometry/cavernosography in patients undergoing surgery for Peyronie's disease: correlation with postoperative results.
Topics: Alprostadil; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penile Induration; Penis; Phentolamine; Preoperative Care; Pressure; Radiography; Skin Transplantation | 1993 |
[Treatment of erectile dysfunction with vacuum pumps].
Topics: Adult; Aged; Alprostadil; Combined Modality Therapy; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Patient Acceptance of Health Care; Penis; Phentolamine; Suction; Vacuum; Venous Insufficiency | 1993 |
Penile erections induced by vasoactive intestinal peptide and sodium nitroprusside.
Topics: Alprostadil; Animals; Cats; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Male; Nitroprusside; Papaverine; Penile Erection; Phentolamine; Vasoactive Intestinal Peptide | 1993 |
Posttraumatic impotence: magnetic resonance imaging and duplex ultrasound in diagnosis and management.
Topics: Adolescent; Adult; Alprostadil; Arteries; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Trauma; Papaverine; Penis; Rupture; Ultrasonography; Urethra | 1993 |
Potentiation of drug-induced erection with audiovisual sexual stimulation.
Topics: Alprostadil; Drug Combinations; Erectile Dysfunction; Erotica; Humans; Male; Middle Aged; Motion Pictures; Papaverine; Penile Erection; Penis; Phentolamine; Regional Blood Flow; Ultrasonics; Ultrasonography | 1993 |
Role of cyclic adenosine monophosphate in prostaglandin E1-induced penile erection in rabbits.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Alprostadil; Animals; Cyclic AMP; Dose-Response Relationship, Drug; Male; Muscle Relaxation; Papaverine; Penile Erection; Penis; Pressure; Rabbits | 1995 |
Papaverine and prostaglandin E1 gel applications for impotence.
Topics: Administration, Cutaneous; Administration, Topical; Alprostadil; Animals; Erectile Dysfunction; Gels; Humans; Iontophoresis; Male; Mice; Mice, Nude; Papaverine; Penile Erection | 1995 |
Reproducibility of penile arterial colour duplex ultrasonography.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Arteries; Blood Flow Velocity; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Reproducibility of Results; Ultrasonography, Doppler, Color; Vasodilator Agents | 1996 |
Epidemiology of current treatment for sexual dysfunction in spinal cord injured men in the USA model spinal cord injury centers.
Topics: Adolescent; Adult; Aged; Alprostadil; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Patient Satisfaction; Penile Prosthesis; Phentolamine; Prospective Studies; Rehabilitation Centers; Spinal Cord Injuries; United States; Vacuum | 1996 |
The rabbit as an intracavernous injection study model.
Topics: Alprostadil; Animals; Feasibility Studies; Injections; Male; Papaverine; Penile Erection; Penis; Pressure; Rabbits; Sodium Chloride | 1996 |
Enhancement of erectile responses to vasoactive drugs by a variable amplitude oscillation device.
Topics: Adult; Aged; Alprostadil; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Physical Stimulation; Pressure; Vasodilator Agents; Vibration | 1996 |
Tissue angiotensin II as a modulator of erectile function. I. Angiotensin peptide content, secretion and effects in the corpus cavernosum.
Topics: Alprostadil; Anesthesia; Angiotensin II; Animals; Dogs; Humans; Injections; Losartan; Male; Papaverine; Penile Erection; Penis | 1997 |
Penile dorsal vein arterialization in managing venogenic impotence.
Topics: Adult; Alprostadil; Anastomosis, Surgical; Coitus; Constriction, Pathologic; Follow-Up Studies; Humans; Impotence, Vasculogenic; Injections; Male; Microsurgery; Middle Aged; Motivation; Nitroglycerin; Papaverine; Patient Selection; Penile Erection; Penis; Peripheral Vascular Diseases; Postoperative Complications; Treatment Outcome; Vasodilator Agents; Veins | 1995 |
[Vascular and functional evaluation of erectile dysfunctions using erection provocation tests].
Topics: Alprostadil; Blood Pressure Determination; Erectile Dysfunction; Humans; Male; Papaverine; Penile Erection; Penis; Ultrasonography, Doppler, Pulsed; Vasodilator Agents | 1997 |
Is diabetic neuropathy responsible for diabetic impotence?
Topics: Algorithms; Alprostadil; Diabetic Neuropathies; Diagnosis, Differential; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Male; Middle Aged; Papaverine; Penile Erection; Stress, Psychological; Vasodilator Agents | 1997 |
The value of a second injection on the pharmaco-induced erection test.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Erection; Phentolamine; Vasodilator Agents | 1997 |
Drop-out reasons and complications in self-injection therapy with a triple vasoactive drug mixture in sexual erectile dysfunction.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Fibrosis; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Self Administration; Treatment Outcome; Vasodilator Agents | 1998 |
Alternative approaches to the management of priapism.
Topics: Adult; Alprostadil; Anemia, Sickle Cell; Embolization, Therapeutic; Enzyme Inhibitors; Guanylate Cyclase; Humans; Male; Methylene Blue; Middle Aged; Papaverine; Priapism; Trazodone; Vasodilator Agents | 1998 |
The effect of re-dosing of vasodilators on the intracavernosal pressure and on the penile rigidity.
Topics: Adult; Aged; Alprostadil; Blood Flow Velocity; Blood Pressure; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Muscle, Smooth; Papaverine; Penile Erection; Penis; Phentolamine; Retreatment; Ultrasonography, Doppler; Vasodilator Agents | 1998 |
Accumulation of platelets as a key mechanism of human erection. A scintigraphic study in patients with erectile dysfunction receiving intracavernous injection of PGE1, papaverine/phentolamine.
Topics: Adult; Aged; Alprostadil; Blood Platelets; Erectile Dysfunction; Humans; Indium Radioisotopes; Male; Middle Aged; Organometallic Compounds; Oxyquinoline; Papaverine; Penile Erection; Penis; Phentolamine; Radionuclide Imaging | 1997 |
Penile fracture after intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penis; Phentolamine; Rupture; Vasodilator Agents | 1998 |
[Methodology of penile isotope imaging. Evaluation].
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Evaluation Studies as Topic; Humans; Image Processing, Computer-Assisted; Impotence, Vasculogenic; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Perchlorates; Potassium Compounds; Radiography; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Technetium; Thyroid Gland; Ultrasonography, Doppler; Ultrasonography, Doppler, Pulsed; Vasodilator Agents | 1998 |
Vasoactive cocktails for erectile dysfunction: chemical stability of PGE1, papaverine and phentolamine.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Chromatography, High Pressure Liquid; Drug Combinations; Drug Interactions; Drug Stability; Drug Storage; Erectile Dysfunction; Humans; Male; Multivariate Analysis; Papaverine; Phentolamine; Time Factors; Vasodilator Agents | 1998 |
Short term use of intracavernous vasoactive drugs in the treatment of persistent psychogenic erectile dysfunction.
Topics: Adult; Alprostadil; Anxiety; Erectile Dysfunction; Humans; Male; Marriage; Middle Aged; Papaverine; Penile Diseases; Penile Erection; Penis; Phentolamine; Retrospective Studies; Self Administration; Vasodilator Agents | 1998 |
Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction.
Topics: Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Phentolamine; Sympatholytics; Vasodilator Agents | 1998 |
Progressive treatment of erectile dysfunction with intracorporeal injections of different combinations of vasoactive agents.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Vasodilator Agents | 1999 |
Maximisation of the erectile response in the investigation of impotence.
Topics: Aged; Alprostadil; Audiovisual Aids; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Vasodilator Agents | 1999 |
Patient-partner satisfaction with intracavernous medication supported with oral agents in selected cases of Peyronie's disease. A ten-month follow-up study.
Topics: Adult; Alprostadil; Colchicine; Drug Administration Routes; Drug Therapy, Combination; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Patient Satisfaction; Penile Induration; Phentolamine; Sexual Partners; Vasodilator Agents; Vitamin E | 1999 |
Intracavernosal therapy for erectile failure--impact of treatment and reasons for drop-out and dissatisfaction.
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Libido; Male; Middle Aged; Papaverine; Patient Satisfaction; Penile Erection; Penis; Phentolamine; Sexual Partners; Surveys and Questionnaires; Time Factors; Treatment Outcome | 1999 |
[Pharmaco-erection in erectile deficiency after surgical therapy].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Cystectomy; Erectile Dysfunction; Humans; Injections; Male; Papaverine; Penile Prosthesis; Phentolamine; Prostatectomy; Testis; Vasodilator Agents | 1999 |
Feline penile erection induced by transurethral administration of sodium nitroprusside.
Topics: Alprostadil; Animals; Blood Pressure; Cats; Dose-Response Relationship, Drug; Male; Nitric Oxide Donors; Nitroprusside; Papaverine; Penile Erection; Phentolamine; Urethra | 1999 |
Comparison of the synergistic effects of tamsulosin versus phentolamine on penile erection: in vitro and in vivo studies.
Topics: Adrenergic alpha-Antagonists; Alprostadil; Animals; Blood Pressure; Dogs; Drug Synergism; Erectile Dysfunction; Humans; In Vitro Techniques; Injections; Male; Middle Aged; Muscle Relaxation; Muscle, Smooth; Papaverine; Penile Erection; Phentolamine; Rabbits; Sulfonamides; Tamsulosin; Vasoactive Intestinal Peptide | 1999 |
A simplified pharmacologic erection program for patients with spinal cord injury.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Patient Satisfaction; Penile Erection; Spinal Cord Injuries; Treatment Outcome; Vasodilator Agents | 1999 |
Differential action of spasmolytic vasodilators on platelet aggregation and endothelial cell-dependent anti-aggregation.
Topics: Alprostadil; Animals; Aorta; Cells, Cultured; Diltiazem; Dose-Response Relationship, Drug; Endothelium, Vascular; Nicardipine; Nitroglycerin; Nitroprusside; Papaverine; Pentobarbital; Platelet Aggregation; Platelet Aggregation Inhibitors; Swine; Sympatholytics; Vasodilator Agents | 2000 |
[Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
Topics: Adult; Aged; Aged, 80 and over; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Phentolamine; Retrospective Studies; Self Administration; Vasodilator Agents | 1998 |
Erectile dysfunction.
Topics: Alprostadil; Drug Interactions; Erectile Dysfunction; Humans; Male; Papaverine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2000 |
Intracavernous injection in the treatment of erectile dysfunction after radical prostatectomy: an observational study.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Phentolamine; Prostatectomy; Retrospective Studies; Self Administration; Treatment Outcome; Vasodilator Agents | 2001 |
Intracavernous injections: still the gold standard for treatment of erectile dysfunction in elderly men.
Topics: Aged; Aged, 80 and over; Aging; Alprostadil; Case-Control Studies; Dose-Response Relationship, Drug; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Treatment Outcome; Vasodilator Agents | 2001 |
Short-term histopathologic effects of different intracavernosal agents on corpus cavernosum and antifibrotic activity of intracavernosal verapamil: an experimental study.
Topics: Alprostadil; Animals; Calcium Channel Blockers; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Erectile Dysfunction; Fibrosis; Humans; Injections; Liver; Liver Diseases; Liver Function Tests; Male; Nitroprusside; Papaverine; Penile Diseases; Penile Erection; Penis; Rats; Rats, Sprague-Dawley; Vasodilator Agents; Verapamil | 2001 |
Diabetic impotence treated by intracavernosal injections: high treatment compliance and increasing dosage of vaso-active drugs.
Topics: Alprostadil; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Patient Compliance; Penile Erection; Self Administration; Vasodilator Agents | 2001 |
Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO.
Topics: alpha-MSH; Alprostadil; Anesthesia; Animals; Blood Pressure; Culture Techniques; Cyclic GMP; Dose-Response Relationship, Drug; Electric Stimulation; Enzyme Inhibitors; Injections, Intravenous; Isometric Contraction; Male; Melanocyte-Stimulating Hormones; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Papaverine; Penis; Peptides, Cyclic; Phentolamine; Rabbits; Receptors, Corticotropin; Receptors, Melanocortin | 2001 |
What nonresponse to intracavernous injection really indicates: a determination by quantitative analysis.
Topics: Adrenergic alpha-Antagonists; Adult; Age Factors; Alprostadil; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Penis; Phentolamine; Time Factors; Vasodilator Agents | 2002 |
Intracavernous injections for erectile dysfunction in patients with cardiovascular diseases and failure or contraindications for sildenafil citrate.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Alprostadil; Atropine; Cardiovascular Diseases; Coitus; Contraindications; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Muscarinic Antagonists; Papaverine; Penis; Phentolamine; Piperazines; Purines; Retreatment; Sildenafil Citrate; Sulfones; Treatment Failure; Vasodilator Agents | 2002 |
Diagnostic steps in the evaluation of patients with erectile dysfunction.
Topics: Adult; Aged; Algorithms; Alprostadil; Diagnosis, Differential; Erectile Dysfunction; Humans; Impotence, Vasculogenic; Injections, Intravenous; Male; Middle Aged; Papaverine; Patient Care Team; Penis; Phentolamine; Physical Examination; Practice Guidelines as Topic; Prolactin; Prostaglandins E; Testosterone; Ultrasonography, Doppler | 2002 |
[Current role of intracavernous therapy in the treatment of erectile dysfunction].
Topics: Adrenergic alpha-Antagonists; Alprostadil; Clinical Trials as Topic; Drug Combinations; Erectile Dysfunction; Fibrosis; Humans; Injections; Male; Papaverine; Patient Acceptance of Health Care; Penile Erection; Penis; Phenoxybenzamine; Phentolamine; Prospective Studies; Self Administration; Vasodilator Agents | 2002 |
Small intestinal submucosa as a tunica albuginea graft material.
Topics: Actins; Alprostadil; Animals; Dose-Response Relationship, Drug; Immunohistochemistry; Intestinal Mucosa; Intestine, Small; Male; Muscle, Smooth; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitroprusside; Papaverine; Penile Erection; Penile Induration; Penis; Phentolamine; Rabbits; RNA, Messenger; Transforming Growth Factor beta; Vasodilator Agents | 2002 |
The incidence and management of priapism in Western Australia: a 16 year audit.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Drainage; Drug Combinations; Erectile Dysfunction; Humans; Incidence; Injections; Male; Metaraminol; Middle Aged; Papaverine; Phentolamine; Phenylephrine; Priapism; Retrospective Studies; Vasodilator Agents; Western Australia | 2003 |
Long-term efficacy and compliance of intracorporeal (IC) injection for erectile dysfunction following radical prostatectomy: SHIM (IIEF-5) analysis.
Topics: Aged; Alprostadil; Antihypertensive Agents; Drug Therapy, Combination; Erectile Dysfunction; Follow-Up Studies; Humans; Male; Middle Aged; Papaverine; Patient Compliance; Penis; Phentolamine; Prostatectomy; Retrospective Studies; Salvage Therapy; Vasodilator Agents | 2003 |
Priapism associated with concurrent use of phosphodiesterase inhibitor drugs and intracavernous injection therapy.
Topics: Adult; Alprostadil; Drug Therapy, Combination; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Priapism; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2003 |
Long-term intracavernous therapy responders can potentially switch to sildenafil citrate after radical prostatectomy.
Topics: Administration, Oral; Aged; Alprostadil; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Middle Aged; Papaverine; Patient Satisfaction; Penis; Phentolamine; Piperazines; Prostatectomy; Purines; Sildenafil Citrate; Sulfones; Surveys and Questionnaires; Treatment Outcome; Vasodilator Agents | 2004 |
Cytotoxicity of different intracavernous vasoactive drugs on cultured endothelial cells of human corpus cavernosum penis.
Topics: Alprostadil; Cell Death; Cells, Cultured; Drug Interactions; Endothelial Cells; Endothelium, Vascular; Erectile Dysfunction; Humans; Hydrogen-Ion Concentration; L-Lactate Dehydrogenase; Male; Papaverine; Penis; Phentolamine; Vasodilator Agents | 2004 |
In vitro viability of human cavernosal endothelial and fibroblastic cells after exposure to papaverine/phentolamine and prostaglandin E1.
Topics: Alprostadil; Cell Survival; Cells, Cultured; Endothelial Cells; Fibroblasts; Fluorescent Antibody Technique; Humans; In Vitro Techniques; Male; Papaverine; Penis; Phentolamine; Phosphodiesterase Inhibitors; Vasodilator Agents | 2005 |
Clinical and duplex US assessment of effects of sildenafil on cavernosal arteries of the penis: comparison with intracavernosal injection of vasoactive agents--initial experience.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Humans; Impotence, Vasculogenic; Injections; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phentolamine; Phosphodiesterase Inhibitors; Piperazines; Prospective Studies; Purines; Sildenafil Citrate; Statistics, Nonparametric; Sulfones; Treatment Outcome; Ultrasonography, Doppler, Duplex | 2005 |
Erectile dysfunction in spinal cord injury: a cost-utility analysis.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Alprostadil; Cost-Benefit Analysis; Drug Costs; Erectile Dysfunction; Female; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penile Prosthesis; Phentolamine; Piperazines; Purines; Quality of Life; Sexual Partners; Sildenafil Citrate; Socioeconomic Factors; Spinal Cord Injuries; Sulfones; Surveys and Questionnaires; Vasodilator Agents | 2005 |
Use of a visual analog scale to assess pain of injection with intracavernous injection therapy.
Topics: Adult; Aged; Alprostadil; Diabetes Mellitus; Drug Administration Routes; Humans; Injections; Male; Middle Aged; Pain; Pain Measurement; Papaverine; Patient Satisfaction; Penis; Phentolamine; Prospective Studies; Severity of Illness Index; Vasodilator Agents | 2005 |
Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction.
Topics: Alprostadil; Diabetes Complications; Dose-Response Relationship, Drug; Drug Combinations; Erectile Dysfunction; Follow-Up Studies; Humans; Injections; Male; Papaverine; Patient Compliance; Penile Erection; Penis; Self Administration; Vasodilator Agents | 2006 |
Different hemodynamic responses by color Doppler ultrasonography studies between sildenafil non-responders and responders.
Topics: Adult; Aged; Alprostadil; Erectile Dysfunction; Humans; Male; Middle Aged; Papaverine; Phentolamine; Piperazines; Purines; Sildenafil Citrate; Sulfones; Ultrasonography, Doppler, Color; Vasodilator Agents | 2007 |
Prospective and long-term evaluation of erect penile length obtained with inflatable penile prosthesis to that induced by intracavernosal injection.
Topics: Aged; Alprostadil; Drug Combinations; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penile Prosthesis; Phentolamine; Prospective Studies | 2009 |
My pet peeve.
Topics: Adrenergic alpha-Antagonists; Advertising; Alprostadil; Atropine; Attitude of Health Personnel; Drug Therapy, Combination; Ejaculation; Humans; Injections, Intravenous; Male; Papaverine; Parasympatholytics; Patient Education as Topic; Penile Induration; Penis; Phentolamine; Sexual Dysfunction, Physiological; Truth Disclosure; Vasodilator Agents | 2010 |
Rehabilitation of the cavernous smooth muscle in patients with organic erectile dysfunction.
Topics: Adult; Alprostadil; Arteries; Coitus; Constriction; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Muscle, Smooth; Papaverine; Penile Erection; Penis; Phentolamine; Piperazines; Purines; Self Administration; Sildenafil Citrate; Sulfones; Treatment Outcome; Vacuum; Vasodilator Agents | 2012 |
Injection anxiety and pain in men using intracavernosal injection therapy after radical pelvic surgery.
Topics: Aged; Alprostadil; Anxiety; Drug Combinations; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Pain; Pain Measurement; Papaverine; Penile Erection; Phentolamine; Self Administration; Surveys and Questionnaires; Time Factors; Treatment Outcome; Urologic Surgical Procedures, Male; Vasodilator Agents | 2013 |
Physicochemical stability study of a new Trimix formulation for treatment of erectile dysfunction.
Topics: Alprostadil; Chemistry, Pharmaceutical; Chromatography, High Pressure Liquid; Drug Combinations; Drug Stability; Drug Storage; Erectile Dysfunction; Humans; Male; Papaverine; Piperazines; Spectrophotometry, Ultraviolet; Syringes; Vasodilator Agents | 2013 |
The role of intracavernosal injection therapy and the reasons of withdrawal from therapy in patients with erectile dysfunction in the era of PDE5 inhibitors.
Topics: Alprostadil; Coitus; Erectile Dysfunction; Humans; Injections; Male; Middle Aged; Papaverine; Patient Satisfaction; Penile Erection; Phentolamine; Phosphodiesterase 5 Inhibitors; Piperazines; Purines; Self Administration; Sildenafil Citrate; Sulfones; Treatment Outcome; Treatment Refusal | 2014 |
[Evaluation of the management of erectile and ejaculatory dysfunction in a series of 90 patients with spinal cord injuries].
Topics: Adolescent; Adrenergic alpha-Agonists; Adult; Aged; Alprostadil; Ejaculation; Erectile Dysfunction; Humans; Male; Massage; Middle Aged; Midodrine; Papaverine; Phosphodiesterase 5 Inhibitors; Phosphodiesterase Inhibitors; Retrospective Studies; Sexual Dysfunction, Physiological; Spinal Cord Injuries; Vasodilator Agents; Vibration; Young Adult | 2013 |
Penile vascular diagnostic categorization using penile duplex Doppler ultrasound: Differences in vascular hemodynamics parameters by differences in anatomic sampling location.
Topics: Alprostadil; Erectile Dysfunction; Hemodynamics; Humans; Male; Middle Aged; Papaverine; Penile Erection; Penis; Phosphodiesterase 5 Inhibitors; Ultrasonography, Doppler, Duplex | 2016 |
Effectiveness and safety of intracoronary papaverine, alprostadil, and high dosages of nicorandil and adenosine triphosphate for measurement of the index of coronary microcirculatory resistance in a pig model.
Topics: Adenosine Triphosphate; Alprostadil; Animals; Coronary Circulation; Microcirculation; Nicorandil; Papaverine; Swine; Vasodilator Agents | 2019 |